Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Eagan

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Cancer Treatment Reports|May 1, 1978
VP-16-213 chemotherapy for advanced squamous cell carcinoma and adenocarcinoma of the lungR T Eagan, J N Ingle, E T Creagan, et al.
Cancer Clinical Trials|January 1, 1981
Thoracic radiation therapy and Adriamycin/cisplatin-containing chemotherapy for locally advanced non-small-cell lung cancerR T Eagan, R E Lee, S Frytak, et al.
Tumori|February 28, 1979
VP-16, cyclophosphamide, adriamycin and cis-platinum (V:CAP-I) in patients with metastatic adenocarcinoma of the lungR T Eagan, E T Creagan, J N Ingle, et al.
Clinical Pharmacology and Therapeutics|June 1, 1976
Clinical comparison of adriamycin and a combination of methyl-CCNU and imidazole carboxamide in disseminated malignant melanomaD L Ahmann, H F Bisel, J H Edmonson, et al.
Cancer Treatment Reports|September 1, 1983
Pharmacokinetics of mitomycin C in patients receiving the drug alone or in combinationG A van Hazel, M Scott, J Rubin, et al.
Cancer Treatment Reports|May 1, 1976
Phase II evaluation of VP-16-213 (NSC-141540) and cytembena (NSC-104801) in patients with advanced breast cancerD L Ahmann, H F Bisel, R T Eagan, et al.
Cancer Treatment Reports|March 1, 1981
Phase II evaluation of PALA in patients with metastatic lung cancerE T Creagan, R T Eagan, T R Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1988
A randomized comparative trial of sequential versus alternating cyclophosphamide, doxorubicin, and cisplatin and mitomycin, lomustine, and methotrexate in metastatic non-small-cell lung cancerR T Eagan, S Frytak, R L Richardson, et al.
Cancer Treatment Reports|July 1, 1981
Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancerR T Eagan, S Frytak, W C Nichols, et al.
American Journal of Clinical Oncology|February 1, 1987
Cyclophosphamide, etoposide, and infusion cisplatin in refractory small cell lung cancer. A preliminary reportS Frytak, R T Eagan, R L Richardson, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Cancer Treatment Reports|May 1, 1978
VP-16-213 chemotherapy for advanced squamous cell carcinoma and adenocarcinoma of the lungR T Eagan, J N Ingle, E T Creagan, et al.
Cancer Clinical Trials|January 1, 1981
Thoracic radiation therapy and Adriamycin/cisplatin-containing chemotherapy for locally advanced non-small-cell lung cancerR T Eagan, R E Lee, S Frytak, et al.
Tumori|February 28, 1979
VP-16, cyclophosphamide, adriamycin and cis-platinum (V:CAP-I) in patients with metastatic adenocarcinoma of the lungR T Eagan, E T Creagan, J N Ingle, et al.
Clinical Pharmacology and Therapeutics|June 1, 1976
Clinical comparison of adriamycin and a combination of methyl-CCNU and imidazole carboxamide in disseminated malignant melanomaD L Ahmann, H F Bisel, J H Edmonson, et al.
Cancer Treatment Reports|September 1, 1983
Pharmacokinetics of mitomycin C in patients receiving the drug alone or in combinationG A van Hazel, M Scott, J Rubin, et al.
Cancer Treatment Reports|May 1, 1976
Phase II evaluation of VP-16-213 (NSC-141540) and cytembena (NSC-104801) in patients with advanced breast cancerD L Ahmann, H F Bisel, R T Eagan, et al.
Cancer Treatment Reports|March 1, 1981
Phase II evaluation of PALA in patients with metastatic lung cancerE T Creagan, R T Eagan, T R Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1988
A randomized comparative trial of sequential versus alternating cyclophosphamide, doxorubicin, and cisplatin and mitomycin, lomustine, and methotrexate in metastatic non-small-cell lung cancerR T Eagan, S Frytak, R L Richardson, et al.
Cancer Treatment Reports|July 1, 1981
Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancerR T Eagan, S Frytak, W C Nichols, et al.
American Journal of Clinical Oncology|February 1, 1987
Cyclophosphamide, etoposide, and infusion cisplatin in refractory small cell lung cancer. A preliminary reportS Frytak, R T Eagan, R L Richardson, et al.
Pageof 12